biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by chance18on Oct 27, 2018 4:51pm

109 Views

Post# 28882841

I agree

We do need a update from the company . I wouldn’t hold your breath for a Nas listing until there is some real news to warrant going on another exchange , I’m thinking late next year at best , or early 2020. It really is a shame we’re sitting at these crazy levels with what we’re told is going on . I would expect they have something to tell or why hire Stern. Sure would like to see us around a dollar or two ,it wouldn’t be so discouraging to keep holding on . Good luck to all who have stuck it out .

Bullboard Posts

Gold, growth and sustainability in focus for Mandalay Resources